Novel Triple-dose Tuberculosis Retreatment Regimen
Conditions: Multidrug-resistant Tuberculosis; Pulmonary Tuberculosis; Tuberculosis; Resistance to Tuberculostatic Drugs Interventions: Drug: 6EH³R³Z; Drug: 6EHRZ Sponsors: Institute of Tropical Medicine, Belgium; Damien Foundation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials